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Abstract: Experimental design method was used for HPLC determination of irbesartan 
and hydrochlorothiazide in combined dosage forms. The traditional approach for 
optimization of experiments is time-consuming, involves a large number of runs and does 
not allow establishing the multiple interacting parameters. The main advantages of the 
experimental design method include the simultaneous screening of a larger number of 
factors affecting response and the estimation of possible interactions. On the basis of 
preliminary experiments, three factors-independent variables were selected as inputs 
(methanol content, pH of the mobile phase and temperature) and as dependent variables, 
five responses (resolution, symmetry of irbesartan peak, symmetry of hydrochlorothiazide 
peak, retention factor of irbesartan and retention factor of hydrochlorothiazide) were 
chosen. A full 23 factorial design, where factors were examined at two different levels 
(“low” and “high”) was used to determine which factors had an effect on the studied 
response. Afterwards, experimental design was used to optimize these influent parameters 
in the previously selected experimental domain. The novelty of our method lies in the 
optimization step accomplished by Derringers desirability function. After optimizing the 
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experimental conditions a separation was conducted on a Supelcosil C18 (150 mm × 4.6 mm, 
5 m particle size) column with a mobile phase consisting of methanol-tetrahydrofuran-
acetate buffer 47:10:43 v/v/v, pH 6.5 and a column temperature of 25 °C. The developed 
method was successfully applied to the simultaneous separation of these drug-active 
compounds in their commercial pharmaceutical dosage forms. 
Keywords: HPLC; experimental design; irbesartan; hydrochlorothiazide  
 
1. Introduction 
Irbesartan [IRB, 2-butyl-3-[[2′-(1H-tetrazol-5-yl)[1,1′-biphenyl]-4-yl]- methyl1-3-diazaspiro-[4,4]-
non-1-en-4-one, Figure 1(a)] is an angiotensin II blocker. Angiotensin II receptor antagonists represent 
a relatively new pharmacological class [1] which acts mainly by selective blockade of AT1 receptors 
and reduces the effects of angiotensin II. They may be used alone or in combination with other 
antihypertensive or diuretic agents. Hydrochlorothiazide [HCT, 6-chloro-3,4-dihydro-2H-1,2,4-
benzothiadiazine-7-sulphonamide-1,1-dioxide, Figure 1(b)] is a diuretic acting on distal convoluted 
tubule. Because of their synergistic anti-hypertensive action, irbesartan and hydrochlorothiazide are 
available on the market as a combined dosage form. 
Figure 1. Structural formulae of irbesartan (a) and hydrochlorothiazide (b). 
     
A literature survey revealed that there are a number of HPTLC [2–5], spectrophotometric [6], and 
spectrofluorometric [7,8], voltammetric [9], capillary zone electrophoretic [10], HPLC [11,12] and 
LC-MS [13,14] methods for determination of the individual drugs (IRB and HCT) or IRB/HCT in 
combination with other drugs. Although a number of methods for the determination of irbesartan and 
hydrochlorothiazide have been reported, there are a limited number of systematic studies for the 
optimization of separation parameters.  
Some published papers have dealt with the optimization procedure for determination either of IRB 
(and other angiotensin-II-receptor antagonist) 15–18 or HCT 19,20, but to the best of our 
knowledge neither of the already published methods has been related to HPLC method optimization 
for simultaneous determination of IRB and HCT. The aim of this work was the evaluation of the 
chromatographic behavior of IRB and HCT using an appropriate experimental design (ED). The main 
advantage of such approach is simultaneous optimization of influencing factors and response variables 
(a) (b) 
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which enables prediction of chromatographic retention and postulation of optimum conditions  
for separation.  
Several statistical approaches could be used for estimating the retention behavior as a function of 
chromatographic conditions. In this work, full factorial design (FFD) and response surface 
methodology (RSM) have been applied. Factorial design enables an estimation of investigated factors 
which have the most importance. Response surface methodology is generally employed in order to 
provide a description of the response pattern in the region of the studied observations and to assist in 
finding the region where the optimal response occurs 21. 
Marketed tablet formulation (Co-Irda tablets, Nobel Ilac, Turkey) containing 150 mg of irbesartan 
and 12.5 mg of hydrochlorthiazide have been analyzed. The significant feature of this combination lies 
in the fact that hydrochlorthiazide is present in minute amounts compared to irbesartan, which makes 
an analysis more complicated and tedious. In the present paper, a fast, simple and accurate HPLC 
method has been proposed without the tedious extraction procedure.  
2. Results and Discussion  
When applying experimental design methodologies, it is advisable to keep the number of variables 
as low as possible in order to avoid very complex response models and large variability. When the 
number of influencing factors is up to four, full factorial design (FFD) is recommended.  
The investigation was carried out in several steps. The objective of the first step in the investigation 
was to perform a screening of the factors that could potentially influence chromatographic retention, 
thus the independent variables were defined during the preliminary study. Some chromatographic 
parameters, such as flow rate were excluded as its influence can usually be predicted by common 
chromatographic theory knowledge. The factors generally selected to optimize the chromatographic 
separation of ionisable compounds are pH and the content of organic solvent of the mobile phase.  
The variations of these parameters induce a variation of the degree of ionization and thus affect 
chromatographic behavior. In addition, column temperature affects retention behavior, thus three 
factors-independent variables were selected as inputs: methanol content, pH of the mobile phase and 
temperature. Since a good separation is characterized by good resolution and since run time is very 
important (from a practical point of view), five responses were chosen as dependent variables: 
resolution (kR), symmetry of the irbesartan peak (SymIRB), symmetry of the hydrochlorothiazide peak 
(SymHCT), retention factor of irbesartan (RtIRB) and retention factor of hydrochlorothiazide (RtHCT). 
The presence of several functional groups in the molecular structures, such as biphenyl, imidazole 
and benzene (Figure 1), makes a RP-HPLC method with PDA detection suitable for the determination. 
Since the RP-HPLC method is based on using a polar mobile phase, a complete description of the 
ionization profile of the examined substances has been used for the evaluation of retention behavior 
and also for the separation. The degree of ionization of the drug strongly affects solubility and 
retention. Additionally, the knowledge of dissociation constant of ionisable compounds at different pH 
values and the solvent composition is also significant to determine the optimal separation conditions in 
reversed phase liquid chromatography (RP-LC). Considering the chemical structures, it is possible to 
establish a number of proton acceptor and donor groups (Figure 2), to assume ionized structures of 
IRB and HCT (Figures 3 and 4) and degrees of ionization depending on the pH (Tables 1 and 2).  
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Figure 2. Proton acceptor (A) and donor groups (D) of IRB and HCT at pH 4 (a,c) and pH 6 (b,d). 






Figure 3. Structural formulae of ionized IRB. 
   
Figure 4. Structural formulae of ionized HCT.  
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Table 1. Percentage of ionization of IRB depending on pH. 
pH 1 2 3 4 5 6 7 8 9 10 11 
%-1 0.08 0.76 7.11 43.34 88.12 94.96 71.43 20.05 2.45 0.25 0.03 
%-2 99.92 99.24 92.89 56.64 11.52 1.24 0.09 0 0 0 0 
%-3 0 0 0 0.02 0.35 3.79 28.47 79.94 97.55 99.75 99.97
Table 2. Percentage of ionization of HCT depending on pH. 
pH 1 2 3 4 5 6 7 8 9 10 11 12 13 
%-1 100 100 100 100 99.99 99.92 99.19 92.33 51.53 4.55 0.05 0 0 
%-2 0 0 0 0 0 0.04 0.41 3.78 21.11 18.65 2.16 0.06 0 
%-3 0 0 0 0 0 0.04 0.39 3.62 20.21 17.85 2.07 0.05 0 
%-4 0 0 0 0 0 0 0.02 0.15 0.84 0.74 0.09 0 0 
%-5 0 0 0 0 0 0 0 0.1 5.78 51.04 59.03 15.56 1.84
%-6 0 0 0 0 0 0 0 0 0.08 0.74 0.86 0.23 0.03
%-7 0 0 0 0 0 0 0 0.01 0.42 3.70 4.28 1.13 0.13
%-8 0 0 0 0 0 0 0 0 0.03 2.72 31.47 82.97 98 
As it can be seen, IRB has two pKa values (4.12, imidazole nitrogen; 7.40, tetrazole nitrogen) and 
at pH 4 it is present as a mixture of molecular (43.34%) and monoprotonated (56.64%) forms.  
The structure of HCT has three pKa values (9.09, sulphonamide group; 9.83 cyclic sulphonamide; 
11.31, secondary amine). At higher pH values, HCT is present as a mixture of different deprotonated 
species. Having in mind the acid-base properties of IRB and HCT, the pH interval from 4.0 to 6.5 was 
chosen for further investigation. In this pH interval, IRB is partially ionized and HCT is completely 
unionized and under these conditions the following order of retention could be expected: HCT, then 
IRB. The retention of a substance is a function of the volume fraction of the organic modifier in the 
mobile phase. Taking into account the variation of the retention factors of compounds with polarity of 
the mobile phase, a range of methanol concentrations from 35% to 55% was selected for investigation. 
The analysis of IRB and HCT was started on a non-polar stationary phase (Supelcosil C18 column, 
150 mm × 4.6 mm, 5 m particle size) with the mobile phase consisting of methanol-tetrahydrofuran- 
acetate buffer (pH of mobile phase was adjusted to 4 with acetic acid). The column temperature was 
set at 35 °C and the flow rate at 0.75 mL/min. Acceptable separation was achieved with methanol- 
tetrahydrofuran-acetate buffer mixtures ranging from 35:10:55 to 55:10:35 (v/v/v), but peak shape and 
run time needed to be improved. In order to evaluate the effect of the most important factor, a 23 full 
factorial design (FFD) with three replicates at the zero level was chosen. The experimental data was 
coded in order to follow the significance of factors in an easier way. Factors and their “low” (−1), 
“high” (+1) and “zero” (0) values are presented in Table 3.  
Table 3. Factors and levels. 
Factors Factor levels (−) (+) (0) 
A CH3OH 35 55 45 
B pH of mobile phase 4.0 6.5 6.0 
C T (°C) 25 50 35 
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A two-level factorial design runs and three replicates of the central point needed 11 runs to 
complete a whole factorial design. As dependent variables, five responses were chosen: Resolution 
(kR), symmetry of irbesartan peak (SymIRB), symmetry of hydrochlorothiazide peak (SymHCT), 
retention factor of irbesartan (RtIRB) and retention factor of hydrochlorothiazide (RtHCT). The matrix of 
experiments and results obtained as an average value of three runs are presented in Table 4. 
Table 4. Factorial design matrix and results of experiments. 
Factors Results 
A B C kR SymIRB SymHCT RtIRB RtHCT 
1 −1 −1 7.11 1.08 1.24 3.727 2.355 
−1 −1 1 25.2 0.97 1.21 9.762 2.48 
0 0 0 5.14 1.26 1.26 3.312 2.412 
−1 −1 −1 27.56 0.97 1.53 14.567 2.79 
1 −1 1 5.8 1.13 1.29 3.225 2.258 
0 0 0 5.95 1.28 1.28 3.68 2.53 
0 0 0 5.33 1.28 1.29 3.447 2.49 
1 1 1 2.52 1.48 1.3 2.605 2.263 
1 1 −1 2.65 1.21 1.31 2.847 2.37 
−1 1 1 11.56 1.49 1.2 5.352 2.51 
−1 1 −1 14.68 1.52 1.46 8.145 2.867 
Appropriate calculations were done with the Design-Expert 7.0 software (Stat-Ease Inc. 
Minneapolis, MN, USA). A second-order interaction model was suggested as a model of relationship 
between input and output and is presented by Equation (1): 
y = b0 + b1A + b2B + b3C + b12AB + b13AC + b23BC + b123ABC (1) 
where b0 is the intercept, bi (b1, b2, b3), bij (b12, b13, b23) and bijk represent the regression coefficient and 
A,B,C represent independent variables. The calculated coefficient and model of polynomial regression 
is presented in Table 5. 
Table 5. Model of coefficients. 
 b0 b1 b2 b3 b12 b13 b23 b123 
kR 12.14 −7.62 −4.28 −0.87 2.35 0.51 0.052 0.24 
SymIRB 1.23 −0.006 0.19 0.036 −0.074 0.044 0.024 0.031 
SymHCT 1.32 −0.032 0 −0.068 0.02 0.078 0 −0.015 
RtIRB 6.28 −3.18 −1.54 −1.04 1.17 0.86 0.28 −0.22 
RtHCT 2.49 −0.18 0.016 −0.11 −0.011 0.058 −0.007 0.0046 
The repetition of the central experimental point provided a precise estimation of the experimental 
errors and the measure of the adequacy of the models (lack of fit). The results were analysed by 
ANOVA method and the results are presented in Table 6. 
The lack of fit test was determined by performing Fischer-F test. The high value of F with a very 
low probability (only model terms with corresponding p-value lesser than 0.05 are significant at 95% 
confindence level) implies that there was no evidence of the models lack-of-fit and the models could 
be accepted as an adequate representation of the data. In addition, the values of R2 and R2 adjusted 
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taking into account the degrees of freedom indicated that the regression model fits the data well.  
The exception is a model which considers the retention time of HCT. Since p is greater than 0.05,  
the model needs reduction in order to improve the relationship between parameters. 
Table 6. Statistical parameters of models obtained by ANOVA. 
 SSmodels SSmodels/df F p R2 R2adj 
kR 663.23 94.75 537.93 0.0019 0.9995 0.9976 
SymIRB 0.38 0.055 409.59 0.0024 0.9993 0.9969 
SymHCT 0.098 0.014 59.97 0.0165 0.9953 0.9787 
RtIRB 126.28 18.04 520.54 0.0019 0.9995 0.9975 
RtHCT 0.37 0.053 14.70 0.0652 Not significant 
The data collected from the performed FFD design led to the following conclusions: it was noticed 
that methanol content in the mobile phase and pH have the largest influence on kR, RtIRB and less 
influence on the other responses. This influence had a minus sign, which means that the higher pH 
values and percentage of methanol in the mobile phase will reduce resolution and retention time of 
IRB. At the same time, the temperature of the column has a positive effect on SymIRB and a negative 
effect on SymHCT. Since the selected responses were not affected in the same manner an additional 
optimization procedure was needed. 
In order to get the best chromatographic performance, the multicriteria methodology was employed 
by means of Derringers desirability function 22. It is based on constructing desirable ranges for  
each response (individual desirable function, di) and establishing an overall desirability function  
(the Derringer desirability function). The Derringers desirability function is defined as the geometric 
mean of individual desirability functions and can be expressed by Equation (2): 
D = (dp11 × dp22 × .... dpnn)1/n (2) 
where n is the number of responses, and pn is the weight of the responses. Weight of the response is the 
relative importance of each individual functions di and may range from 0.1 to 10. With a weight of 1, 
di varies in a linear way. In this study, weights equal to 1 was selected. 
Individual desirability functions range from 0 (undesired response) to 1 (a fully desired response). 
A value of D close to 1 means that the combination of different criteria is globally optimal. If any of 
the responses or factors falls outside their desirability range, the overall function becomes zero. There 
are several ways for calculating the desirability function depending on the goal desired.  
The meanings of the goal parameters are: 
Maximum: 
di = 0 if response < low value; 0  di  1 as response varies from low to high; di = 1 if response >  
high value 
Minimum: 
di = 1 if response < low value; 1  di  0 as response varies from low to high; di = 0 if response >  
high value  
Molecules 2012, 17 3468 
 
Target: 
di = 0 if response < low value; 0  di  1 as response varies from low to target; 1  di  0 as response 
varies from target to high; di = 0 if response > high value 
Range: 
di = 0 if response < low value; di = 1 as response varies from low to high; di = 0 if response >  
high value. 
The goals of multicriteria optimization for each response in this paper are shown in Table 7. 
Table 7. Criteria for multivariate optimization of the individual responses. 
 Goal Lower limit Upper limit Weight Importance
Percentage of methanol In range −1 1 1 3 
pH In range −1 1 1 3 
T In range −1 1 1 3 
kR Is target = 3 2.52 27.56 1 3 
Sym IRB In range 0.97 1.52 1 1 
Sym HCT In range 1.2 1.53 1 1 
Rt IRB Is target = 5 2.605 14.567 1 5 
Rt HCT In range 2.258 2.867 1 5 
Desirability function calculations were performed using Design-Expert 7.0. Obtained results are 
graphically presented (Figure 5). 
Figure 5. Graphical representation of the constraints accepted fot the determination of 
global desirabilty and obtained optimal conditions.  
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For better visualization of the results, the global desirability function D was presented in a form of a 
three-dimensional plot and presented in Figure 6. 
Figure 6. 3-D plots of the Derringer’s desirability function in correlation with a variation 
of methanol content and pH (a), methanol content and temperature (b) and pH of mobile 
phase and temperature of column (c).  
 
    
The coordinates related to the functions maximum are selected as the best operating conditions. The 
best chromatographic conditions are achieved with coded values of: % of methanol 0.19, pH of mobile 
phase 1 and column’s temperature −1, i.e., with mobile phase methanol:tetrahydrofuran:acetate buffer 
from 47:10:43 v/v/v, pH 6.5 and columns temperature 25 °C. The representative chromatogram taken 
under these conditions is represented in Figure 7.  
Figure 7. LC-PDA chromatogram of hydrochlorothiazide and irbesartan taken under 
optimized experimental conditions.  
 
After setting the optimal conditions, the proposed method was validated. Interfering peaks were not 
detected at the retention time of IRB and HCT, indicating the good selectivity of the method. Linear 
dependence of the peak areas versus concentration was determined for the proposed ranges. 
(a) (c) (b) 
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Parameters of the linear regression equations were calculated and are presented in Table 8. The 
statistical significance of the intercept was tested using Student’s t-test. The limit of detection (LOD) 
and limit of quantification (LOQ) were calculated as LOD = 3/S and LOQ = 10/S, where  is the 
standard deviation of the response and S the intercept determined from the corresponding calibration curve. 
Table 8. Statistical parameters for individual calibration curves. 
Parameter IRB HCT 
Concentration range (mg/mL) 0.08–0.4 0.02–0.1 
Slope 2.448 8.609 
Intercept 0.035 0.0732 
R2 0.9976 0.9954 
Sa 0.007 0.076 
Sb 0.812 0.021 
t * 1.872 1.256 
LOD 0.02 0.006 
LOQ 0.06 0.018 
* ttab = 2.447 (p = 0.05, f = 6). 
Precision of the procedure was assessed by analyzing nine solutions containing known quantities of 
the investigated compounds. Law values of relative standard deviation for repeatability, RSD < 2.5%, 
and high recovery (Table 9) indicate very good precision of the proposed method. 
Table 9. Precision of the RP-HPLC method. 
Sample Injected (mg/mL) Found (mg/mL) RSD (%) 
Irbesartan  0.120 121.29 ± 0.13 1.26 
0.160 160.09 ± 0.15 1.35 
0.190 191.75 ± 0.21 1.54 
Hydrochlorothiazide 0.040 0.040 ± 0.91 0.44 
0.050 0.050 ± 0.82 0.53 
0.060 0.060 ± 0.87 0.59 
The applicability of the proposed method was examined by analysing commercially available  
Co-Irda tablets. 
3. Experimental 
3.1. Drugs and Reagents 
The irbesartan and hydrochlorothiazide standards and Co-Irda tablets (Nobel Ilac, Istanbul, Turkey) 
consisting of 150 mg IRB and HCT were obtained from Zada Pharmaceuticals d.o.o. (Tuzla, Bosnia 
and Herzegovina).  
All solvents: methanol, tetrahydrofuran and sodium-acetate (purchased by Chromosol, Sigma-Aldrich, 
Munich, Germany), and acetic acid (Fluka, Eindhoven, The Netherlands) were of a grade suitable for 
high-performance liquid chromatography analysis. The HPLC analyses were done by using a Thermo 
Finnigan Surveyor chromatographic system equipped with a PDA detector and sample injections were 
Molecules 2012, 17 3471 
 
made through an injector valve with a 5 L sample loop. Separations were performed on a Supelcosil 
C18 column (150 mm × 4.6 mm, 5 m particle size) with detection at 271 nm. Mobile phases were 
prepared according to the plan of the experiments given in Table 4. The resulting mobile phases were 
degassed and vacuum filtered through a 0.45 m membranes filter (Alltech Associates, Lokeren, 
Belgium). The flow rate was 0.75 mL/min. 
3.2. Software 
Experimental design, statistical analysis and desirabiity function calculation were performed by 
using MarvinSketch 5.8.2 (Chem Axon Ltd., Somerville, MA, USA, and Budapest, Hungary) and 
Design-Expert 7.0 (Stat-Ease Inc.). 
3.3. Solutions 
Stock solutions were prepared by dissolving standard substances in methanol to obtain 
concentrations of 0.8 mg/mL for IRB and 0.2 mg/mL for IRB.  
3.3.1. Solutions for Method Optimization  
Stock solutions were diluted with methanol to obtain a concentration of 0.08 mg/mL of IRB and 
0.02 mg/mL of HCT. 
3.3.2. Standard Solutions for Linearity Testing 
For the calibration curves, a series of eight solutions were prepared from stock solution in the 
concentration range from 0.08 to 0.4 mg/mL for IRB and from 0.02 to 0.1 mg/mL for HCT. 
3.3.3. Solutions for Accuracy Testing 
The laboratory mixture containing placebo, IRB and HCT was prepared in the ratio related to the 
investigated tablets. For the quantiative analysis, three solutions corresponding to 80%, 100% and 
120% to those in tablets were prepared. 
3.3.4. Solutions for Estimating Precision 
In order to estimate precision, three series (0.16, 0.24 and 0.32 mg/mL for IRB; 0.04, 0.06 and  
0.08 mg/mL for HCT) were prepare with ten solutions for each of the concentrations. 
3.3.5. Sample Solutions 
A tablet mass which corresponds to 150 mg IRB and 12.5 mg HCT was dissolved in 100 mL 
volumetric flask with methanol, placed into a ultrasonic bath and filtrated. 2 mL of filtrate were diluted 
with methanol to 10 mL.  
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4. Conclusions 
Experimental design methodology was used for simultaneous HPLC determination of irbesartan 
and hydrochlorothiazide in combined dosage forms. The significant feature of these combinations lies 
in the fact that hydrochlorothiazide is present in minute amounts compared to irbesartan which makes 
for a more complicated and tedious analysis.  
The chemometric approach for optimization of chromatographic separation of irbesartan and 
hydrochlorothiazide has been demonstrated. The chemometric methodology chosen for the particular 
objectives was very successful in the retention behavior exploration. Since there was a mix of linear 
responses with different targets, Derringers desirability function was applied. After defining a global 
desirability according to the accepted constraints, optimal chromatographic conditions were established.  
The proposed HPLC method was validated according to ICH guidelines. From the study of 
validation parameters, it was observed that the method is specific, accurate, precise, reproducible and 
is not time-consuming (run time is less than six minutes). Since there was no interference from other 
components present in the dosage forms, complicated procedures for extraction were not required.  
The results obtained in this study corroborate that the proposed HPLC method can be used for routine 
quantitative analyses of the investigated compounds in a mixture or for their individual determination 
in pharmaceutical dosage forms. 
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